Stay updated on Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial page.

Latest updates to the Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page’s interface/version footer was updated from “v3.5.2” to “v3.5.3,” reflecting a change to the ClinicalTrials.gov release rather than study content.SummaryDifference0.0%

- Check27 days agoChange DetectedAdded Revision: v3.5.2; removed Revision: v3.5.0.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page now displays Revision: v3.5.0, replacing the previous Revision: v3.4.3.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page update adds site revision v3.4.3 and removes v3.4.2, indicating an administrative update to the site.SummaryDifference0.0%

- Check93 days agoChange DetectedAdded Revision: v3.4.2 and removed Revision: v3.4.1, reflecting a minor site version update.SummaryDifference0.0%

- Check100 days agoChange DetectedRevision: v3.4.1 was added and Revision: v3.4.0 was removed.SummaryDifference0.0%

Stay in the know with updates to Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial page.